Myozyme and dyspnoea 
Myozyme and dyspnoea Patient Reports February 12, 2012
Myozyme Side Effects Report #5677967-7
Myozyme side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2008. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, chest discomfort, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity, nausea , pallor. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5796386-6
Myozyme side effect was reported by a Physician from UNITED STATES on June 19, 2008. Female patient, child 9 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arthralgia, blood immunoglobulin g increased, catheter site erythema, catheter site pruritus, cough, dyspnoea, flushing, headache
. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BENADRYL. Patient recovered.Myozyme Side Effects Report #5799564-5
Myozyme side effect was reported by a Health Professional from UNITED STATES on June 20, 2008. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, aphasia , blood pressure increased, chest discomfort, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5832451-2
Myozyme side effect was reported by a Physician from UNITED STATES on July 21, 2008. Female patient, child 9 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: arthralgia, chest discomfort, cough, cyanosis, dysgeusia, dyspnoea, face oedema, flushing, headache
. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BENADRYL. Patient recovered.Myozyme Side Effects Report #6055334-4
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 02, 2009. Female patient, child 9 years of age, weighting 66.14 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, blood pressure increased, chest discomfort, circumoral oedema, cyanosis, dyspnoea, eye swelling, flushing, hypersensitivity. Myozyme dosage: 20 MG/KG, Q2W; INTRAVENOUS. During the same period patient was treated with FLONASE, CONCERTA, ALBUTEROL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5140646-9
Myozyme side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 11, 2006. Male patient, child 6 years of age, weighting 33.07 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea, post procedural complication. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5154608-9
Myozyme side effect was reported by a Health Professional from KOREA, REPUBLIC OF on Oct 29, 2006. Male patient, child 6 years of age, weighting 33.07 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5325824-8
Myozyme side effect was reported by a Physician from GERMANY on Apr 26, 2007. Female patient, 58 years of age, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, erythema, oxygen saturation decreased, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5353601-0
Myozyme side effect was reported by a Physician from FRANCE on May 25, 2007. Male patient, 57 years of age, weighting 216.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, fatigue, lung infection, pulmonary congestion. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with MUCOMYST. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5248067-5
Myozyme side effect was reported by a Physician from GERMANY on Feb 08, 2007. Female patient, 55 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, dyspnoea, infusion related reaction, oxygen saturation decreased, respiratory distress. Myozyme dosage: 1200 MG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5424555-3
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 03, 2007. Female patient, 52 years of age, weighting 138.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5196519-9
Myozyme side effect was reported by a Physician from PORTUGAL on Dec 07, 2006. Female patient, child 5 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, cardio-respiratory arrest, cyanosis, dyspnoea, nasopharyngitis. Myozyme dosage: unknown. Patient died on 12/07/2006.
Myozyme Side Effects Report #5538424-1
Myozyme side effect was reported by a Physician from PORTUGAL on Nov 21, 2007. Female patient, child 5 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, cyanosis, dyspnoea, mydriasis, nasopharyngitis. Myozyme dosage: 20 MG Q2WKS IV. During the same period patient was treated with AMOXICILLIN. Patient died on 12/07/2006.
Myozyme Side Effects Report #5761739-9
Myozyme side effect was reported by a Health Professional from UNITED STATES on May 16, 2008. Female patient, 48 years of age, weighting 165.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac disorder, chest discomfort, contusion, dyspnoea, hypersensitivity, infusion related reaction, septal panniculitis. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, SYNTHROID, VESICARE, ZOLOFT. Patient recovered.
Myozyme Side Effects Report #5775965-6
Myozyme side effect was reported by a Physician from UNITED STATES on May 30, 2008. Female patient, 48 years of age, weighting 165.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, dyspnoea, flushing, hypersensitivity, throat tightness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, SYNTHROID, VESICARE, ZOLOFT. Patient recovered.
Myozyme Side Effects Report #5933430-7
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Female patient, 48 years of age, weighting 165.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, dyspnoea, flushing, hypersensitivity, throat tightness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, SYNTHROID, VESICARE, ZOLOFT. Patient recovered.
Myozyme Side Effects Report #5567550-6
Myozyme side effect was reported by a Physician from AUSTRALIA on Dec 05, 2007. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood ph increased, bronchiectasis, dyspnoea, pco2 decreased, pneumothorax, po2 increased, pulmonary fibrosis
, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, ESOMEPRAZOLE, CITALOPRAM HYDROBROMIDE, OXYBUTYNIN CHLORIDE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5201827-9
Myozyme side effect was reported by a Physician from HUNGARY on Dec 21, 2006. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, dizziness
, dyspnoea, fall , fatigue, hyperhidrosis, hypertension, muscular weakness, pallor. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN. Patient recovered.Myozyme Side Effects Report #5211742-2
Myozyme side effect was reported by a Physician from HUNGARY on Dec 30, 2006. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, anaphylactic reaction, chest pain
, dizziness , dyspnoea, hyperhidrosis, hypertension, muscular weakness. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN, TELFAST, CALCIUM, CALCIUM GLUCOMATE. Patient recovered.Myozyme Side Effects Report #5236949-X
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Female patient, 37 years of age, weighting 112.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, chest discomfort, chest pain
, dyspnoea, feeling abnormal, infusion related reaction, rash , throat tightness, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL, TOPROL, CELEBREX, PAXIL. Patient recovered.Myozyme Side Effects Report #5614459-5
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 21, 2008. Female patient, 37 years of age, weighting 112.2 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain
, blood immunoglobulin e increased, blood immunoglobulin g increased, chest discomfort, chest pain , dyspnoea, infusion related reaction, oedema peripheral, rash . Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, BENADRYL, TOPROL, CELEBREX, PAXIL. Patient recovered.Myozyme Side Effects Report #5681125-X
Myozyme side effect was reported by a Physician from GERMANY on Mar 11, 2008. Female patient, 36 years of age, weighting 147.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypersensitivity, infusion related reaction, obstructive airways disorder, stridor. Myozyme dosage: unknown. During the same period patient was treated with RANITIDINE, FENISTIL, PREDNISOLONE, EFEROX, ORGAMETRIL, LYRICA. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5755486-7
Myozyme side effect was reported by a Physician from GERMANY on May 19, 2008. Female patient, 36 years of age, weighting 147.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea, hypersensitivity, infusion related reaction, stridor. Myozyme dosage: unknown. During the same period patient was treated with RANITIDINE, FENISTIL, PREDNSOLON, EFEROX, ORGAMETRIL, LYRICA. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5383418-2
Myozyme side effect was reported by a Physician from GERMANY on June 25, 2007. Female patient, 35 years of age, weighting 149.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthma
, dyspnoea, hypersensitivity. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with EFEROX, ORGAMETRIL, LYRICA. Patient recovered.Myozyme Side Effects Report #5336329-2
Myozyme side effect was reported by a Physician from UNITED STATES on May 09, 2007. Female patient, 33 years of age, weighting 160.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness
, dyspnoea, flushing, headache , hypersensitivity, nausea , oxygen saturation decreased, peak expiratory flow rate decreased. Myozyme dosage: 10 MG/KG QWK IV. During the same period patient was treated with PREDNISONE, SYNTHROID, NAPROXEN, HYDROCODONE BITARTRATE, HYDROCORTISONE. Patient recovered.Myozyme Side Effects Report #5945820-7
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Oct 27, 2008. Female patient, 33 years of age, weighting 110.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure increased, dyspnoea, feeling hot, flushing, heart rate increased. Myozyme dosage: 1000 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5960897-0
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2008. Female patient, 33 years of age, weighting 110.7 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure increased, dyspnoea, feeling hot, flushing, heart rate increased. Myozyme dosage: 1000 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #6005617-9
Myozyme side effect was reported by a Health Professional from UNITED KINGDOM on Dec 08, 2008. Female patient, 33 years of age, weighting 112.9 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, dizziness
, dyspnoea, feeling hot, flushing, heart rate decreased, heart rate increased, hypotension, immunology test abnormal. Myozyme dosage: 1000 MG/DAY, Q2W, INTRAVENOUS. During the same period patient was treated with CHLORPHENIRAMINE MALEATE, ACETAMINOPHEN. Patient recovered.Myozyme Side Effects Report #5715787-5
Myozyme side effect was reported by a Physician from SWEDEN on Mar 30, 2008. Female patient, 32 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: caesarean section, dyspnoea, hypoventilation. Myozyme dosage: unknown. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5285777-8
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 07, 2006. Male patient, 28 years of age, weighting 95.68 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, nausea
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.Myozyme Side Effects Report #5166543-0
Myozyme side effect was reported by a Physician from TURKEY on Nov 15, 2006. Female patient, 28 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea, hypersensitivity, infusion related reaction, rash
. Myozyme dosage: unknown. Patient recovered.Myozyme Side Effects Report #5302486-7
Myozyme side effect was reported by a Physician from SPAIN on Mar 03, 2007. Female patient, 27 years of age, weighting 94.80 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: body temperature increased, cough, dyspnoea, leukopenia, lymphocyte count increased, malaise, monocyte count increased, neutropenia, neutrophil count decreased. Myozyme dosage: 800 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5339036-5
Myozyme side effect was reported by a Physician from ARGENTINA on May 11, 2007. Male patient, child 2 years of age, weighting 32.23 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea, pyrexia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, FLUTICASONE PROPIONATE, SALBUTAMOL. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5757711-5
Myozyme side effect was reported by a Physician from COLOMBIA on May 19, 2008. Male patient, 13 years of age, weighting 99.21 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, pneumonia
, productive cough, pyrexia. Myozyme dosage: 19 MG/KG, QOW, INTRAVENOUS. During the same period patient was treated with THEOPHYLLINE, FLUOXETINE, SALBUTAMOL. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5518847-7
Myozyme side effect was reported by a Physician from SPAIN on Oct 29, 2007. Male patient, child 1 years of age, weighting 27.56 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, cyanosis, disease recurrence, dyspnoea, infusion related reaction, nasopharyngitis, respiratory arrest, respiratory tract infection, transaminases increased. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ACTOCORTINA, SPIRONOLACTONE, CARVEDILOL. Patient recovered.
Myozyme Side Effects Report #5159354-3
Myozyme side effect was reported by a Physician from SPAIN on Nov 06, 2006. Male patient, weighting 18.08 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea, respiratory arrest, respiratory failure, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with FUROSEMIDE, HYDROCHLOROTHIAZIDE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5442437-8
Myozyme side effect was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, weighting 15.43 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac disorder, dyspnoea, heart rate decreased, infection
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5449823-0
Myozyme side effect was reported by a Physician from SPAIN on Aug 27, 2007. Male patient, weighting 27.56 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, bronchospasm, cyanosis, dyspnoea, hyperhidrosis, infusion related reaction, lip oedema, nasopharyngitis, pharyngeal oedema. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, ACTOCORTINA, SPIRONOLACTONE, CARVEDILOL. Patient recovered.
Myozyme Side Effects Report #5455578-6
Myozyme side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Female patient, weighting 15.43 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac disorder, dyspnoea, heart rate decreased, infection
. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient died on 08/30/2007.Myozyme Side Effects Report #5635628-4
Myozyme side effect was reported by a Physician from FRANCE on Feb 05, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, crying, cyanosis, dyspnoea, erythema, infusion related reaction, moaning, nervousness, pyrexia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5678162-8
Myozyme side effect was reported by a Physician from FRANCE on Mar 05, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, cyanosis, dyspnoea, erythema, hyperthermia, infusion related reaction, lacrimation increased, moaning, nervousness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, LEVOCARNIL, DEXTRIN. Patient recovered.
Myozyme Side Effects Report #5714330-4
Myozyme side effect was reported by a Physician from ISRAEL on Apr 10, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5724268-4
Myozyme side effect was reported by a Physician from FRANCE on Apr 21, 2008. Female patient, weighting 13.67 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, crying, cyanosis, dyspnoea, erythema, hyperthermia, moaning, nervousness. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, LEVOCARNIL, DEXTRIN. Patient recovered.
Myozyme Side Effects Report #5724720-1
Myozyme side effect was reported by a Health Professional from ISRAEL on Apr 18, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5747234-1
Myozyme side effect was reported by a Physician from ISRAEL on Apr 27, 2008. Male patient, weighting 21.83 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, cyanosis, dyspnoea, hypersensitivity, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL. Patient recovered.
Myozyme Side Effects Report #5753890-4
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on May 16, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5894672-2
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 10, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, blood creatine phosphokinase increased, bradycardia, collapse of lung, dysphagia, dyspnoea, hepatomegaly, hypertrophic cardiomyopathy, hypotonia. Myozyme dosage: 40 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with CARVEDILOL, LASIX. Patient recovered.
Myozyme Side Effects Report #5930343-1
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 17, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5945822-0
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 24, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5988374-1
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Nov 24, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, blood pressure increased, bronchial obstruction, bronchospasm, dyspnoea, hypersensitivity, infusion related reaction, irritability. Myozyme dosage: 200 MG, QW, INTRAVENOUS : 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5995076-4
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Dec 05, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, blood pressure increased, bronchial obstruction, bronchospasm, dyspnoea, hypersensitivity, irritability, nosocomial infection, oxygen saturation decreased. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.